Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Carlo Tur
Observed names:
C. Tur,
Tur, Carlo
Institutions:
Università Cattolica del Sacro Cuore,
Friedrich-Alexander-Universität Erlangen-Nürnberg,
Agostino Gemelli University Polyclinic,
Universitätsklinikum Erlangen,
Istituti di Ricovero e Cura a Carattere Scientifico
Observed institutions:
Università Cattolica del Sacro Cuore,
Friedrich-Alexander-Universität Erlangen-Nürnberg,
Agostino Gemelli University Polyclinic,
Universitätsklinikum Erlangen,
Istituti di Ricovero e Cura a Carattere Scientifico,
Otto-von-Guericke-Universität Magdeburg
show all 6
ORCID:
0009-0003-6241-6116
Observed ORCID:
0009-0003-6241-6116
OpenAlex ID:
A5048343083
CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up
2024
·
Fabian Müller
, Jule Taubmann
, et al.
·
New England Journal of Medicine
·
1,278
CD19-CAR T-cell therapy induces deep tissue depletion of B cells
2024
·
Carlo Tur
, Markus Eckstein
, et al.
·
Annals of the Rheumatic Diseases
·
229
PDF
Bispecific T cell engager therapy for refractory rheumatoid arthritis
2024
·
Laura Bucci
, Melanie Hagen
, et al.
·
Nature Medicine
·
210
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
2024
·
Melanie Hagen
, Laura Bucci
, et al.
·
New England Journal of Medicine
·
167
CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series
2024
·
Janina Auth
, Fabian Müller
, et al.
·
The Lancet Rheumatology
·
153
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial
2026
·
Fabian Müller
, Melanie Hagen
, et al.
·
Nature Medicine
·
119
PDF
BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells
2025
·
Fabian Müller
, Andreas Wirsching
, et al.
·
Nature Medicine
·
97
Effects of different B-cell-depleting strategies on the lymphatic tissue
2025
·
Carlo Tur
, Markus Eckstein
, et al.
·
Annals of the Rheumatic Diseases
·
75
PDF
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease
2025
·
Laura Bucci
, Sebastian Böltz
, et al.
·
New England Journal of Medicine
·
45
Telemedicine will not keep us apart in COVID-19 pandemic
2020
·
Simone Perniola
, Stefano Alivernini
, et al.
·
Annals of the Rheumatic Diseases
·
22
Pos0030 Safety and Preliminary Efficacy of Cd19 Car-t Cell Treatment in Rheumatic Disease- Data From the First Part of the Phase I/ii Castle Basket Study
2024
·
G. Schett
, D. Bohr
, et al.
·
Annals of the Rheumatic Diseases
·
10
Op0027 Long-term Safety and Efficacy of Car-t Cell Treatment in Severe and Treatment Refractory Autoimmune Disease
2024
·
J. Taubmann
, F. Müller
, et al.
·
Annals of the Rheumatic Diseases
·
10
Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells
2026
·
Aleix Rius Rigau
, Meilin Xu
, et al.
·
Nature Communications
·
6
PDF
Pos0062 Safety and Preliminary Efficacy of Cd19 Car T-cell Treatment in Rheumatic Disease – Data From the Phase I/ii Castle Basket Study
2025
·
M. Hagen
, A. Wirsching
, et al.
·
Annals of the Rheumatic Diseases
·
6
Minimally invasive retrieval and characterisation of tenosynovial tissue in rheumatoid arthritis: a novel approach to study at-risk, active, and remission stages
2025
·
Lavinia Agra Coletto
, Hanna W. van Steenbergen
, et al.
·
Annals of the Rheumatic Diseases
·
6
PDF
Update on Monocentric CD19-CAR T-Cell Therapy in 30 Patients with Autoimmune Disease
2024
·
Fabian Mueller
, Melanie Hagen
, et al.
·
Blood
·
5
PDF
Abs0364 Safety and Efficacy of T Cell Engager Therapy in Patients With Refractory Autoimmune Disease
2025
·
L. Bucci
, S. Boeltz
, et al.
·
Annals of the Rheumatic Diseases
·
4
Low-dose blinatumomab in multidrug-resistant rheumatoid arthritis—a case series
2026
·
Laura Bucci
, Melanie Hagen
, et al.
·
Annals of the Rheumatic Diseases
·
3
Minimally invasive ultrasound-guided biopsy of the common extensor tendon enthesis: a cadaveric study to standardise the technique
2025
·
Chiara Rizzo
, Luis Coronel
, et al.
·
RMD Open
·
3
PDF
OP0320 EFFICACY OF CD19-TARGETING CAR T CELL TREATMENT IN PATIENTS WITH DIFFUSE SYSTEMIC SCLEROSIS (dSSc) – AN OPEN LABEL, SINGLE-CENTER PILOT STUDY
2024
·
J. Auth
, F. Müller
, et al.
·
Annals of the Rheumatic Diseases
·
3
Response to the correspondence on “CD19-CAR T-cell therapy induces deep tissue depletion of B cells”
2025
·
Carlo Tur
, Markus Eckstein
, et al.
·
Annals of the Rheumatic Diseases
·
2
Op0193 Biteing Multi-drug Resistant Rheumatoid Arthritis With Cd19-t Cell Engagers
2024
·
L. Bucci
, M. Hagen
, et al.
·
Annals of the Rheumatic Diseases
·
2
Reply to Correspondence on: ‘Effects of different B-cell-depleting strategies on the lymphatic tissue’
2025
·
Carlo Tur
, Markus Eckstein
, et al.
·
Annals of the Rheumatic Diseases
·
1
Safety and preliminary efficacy of anti-CD19 CAR T cells zorpocabtagene-autoleucel in systemic autoimmune diseases: Final analysis of the castle trial
2025
·
Fabian Müller
, Melanie Hagen
, et al.
·
Blood
·
1
PDF
Pos0340 Effects of Car-t Cell Treatment on B Cell Immunity in Systemic Autoimmune Diseases
2024
·
L. Bucci
, T. Rothe
, et al.
·
Annals of the Rheumatic Diseases
·
1
Show more works
View as search
Works count:
36
Citation count:
2,458
H-index:
10
I10-index:
12
Year
Topic
Type